Browsing "Endocrinology & Metabolism" by Keyword : Heart Failure

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 6 to 9 of 9

Pub YearTitleAuthor(s)
2023Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study김대중, 하경화
2023Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia김대중, 하경화
2019Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study김대중, 하경화
2021Trends in cardiovascular complications and mortality among patients with diabetes in South Korea김대중, 하경화
1

Browse